Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

LeMaitre Vascular stock

LMAT
US5255582018
A0LB2B

Price

95.42
Today +/-
+3.57
Today %
+3.93 %

LeMaitre Vascular stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the LeMaitre Vascular stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the LeMaitre Vascular stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the LeMaitre Vascular stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze LeMaitre Vascular's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

LeMaitre Vascular Stock Price History

DateLeMaitre Vascular Price
1/3/202595.42 undefined
1/3/202591.74 undefined
1/2/202591.47 undefined
12/31/202492.14 undefined
12/30/202492.95 undefined
12/27/202492.84 undefined
12/26/202494.04 undefined
12/24/202492.63 undefined
12/23/202491.38 undefined
12/20/202492.12 undefined
12/19/202492.25 undefined
12/18/202490.34 undefined
12/17/202490.93 undefined
12/16/202492.10 undefined
12/13/2024100.69 undefined
12/12/2024100.28 undefined
12/11/2024101.00 undefined
12/10/202499.40 undefined
12/9/202497.23 undefined
12/6/2024101.12 undefined

LeMaitre Vascular Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into LeMaitre Vascular, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by LeMaitre Vascular from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects LeMaitre Vascular’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of LeMaitre Vascular. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into LeMaitre Vascular’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing LeMaitre Vascular’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on LeMaitre Vascular’s growth potential.

LeMaitre Vascular Revenue, EBIT and net profit per share

DateLeMaitre Vascular RevenueLeMaitre Vascular EBITLeMaitre Vascular Net Income
2029e334.46 M undefined82.52 M undefined0 undefined
2028e306.82 M undefined74.15 M undefined0 undefined
2027e290.66 M undefined76.88 M undefined59.5 M undefined
2026e266.52 M undefined68.49 M undefined54.8 M undefined
2025e246.1 M undefined61.13 M undefined49.68 M undefined
2024e224.51 M undefined53.85 M undefined44.56 M undefined
2023193.48 M undefined37.2 M undefined30.11 M undefined
2022161.7 M undefined29.9 M undefined20.6 M undefined
2021154.4 M undefined36.4 M undefined26.9 M undefined
2020129.4 M undefined28.3 M undefined21.2 M undefined
2019117.2 M undefined21.2 M undefined17.9 M undefined
2018105.6 M undefined20.7 M undefined22.9 M undefined
2017100.9 M undefined21.1 M undefined17.2 M undefined
201689.2 M undefined16.3 M undefined10.6 M undefined
201578.4 M undefined11.1 M undefined7.8 M undefined
201471.1 M undefined7.1 M undefined3.9 M undefined
201364.5 M undefined4.5 M undefined3.2 M undefined
201256.7 M undefined4.1 M undefined2.6 M undefined
201157.7 M undefined5.2 M undefined2.1 M undefined
201056.1 M undefined6.3 M undefined6 M undefined
200950.9 M undefined3.8 M undefined1.6 M undefined
200848.7 M undefined-1.2 M undefined-3.3 M undefined
200741.4 M undefined-2.9 M undefined-2.9 M undefined
200634.6 M undefined-300,000 undefined-1.2 M undefined
200530.7 M undefined1.4 M undefined100,000 undefined
200426.2 M undefined1.6 M undefined900,000 undefined

LeMaitre Vascular Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
2026303441485056575664717889100105117129154161193224246266290306334
-30.0015.3813.3320.5917.074.1712.001.79-1.7514.2910.949.8614.1012.365.0011.4310.2619.384.5519.8816.069.828.139.025.529.15
70.0069.2370.0073.5373.1768.7574.0073.2170.1871.4370.3167.6169.2369.6670.0069.5267.5265.1265.5864.6065.8056.7051.6347.7443.7941.5038.02
141821253033374140404548546270737984101104127000000
000-1-2-3162233710172217212620304449545900
----100.0050.00-133.33500.00-66.67-50.00-133.3342.8670.0029.41-22.7323.5323.81-23.0850.0046.6711.3610.209.26--
---------------------------
---------------------------
15.315.38.79.915.415.615.916.11615.615.81718.319.22020.220.320.521.522.222.42000000
---------------------------
Details

Keystats

ⓘ

Revenue and Growth

The LeMaitre Vascular Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the LeMaitre Vascular is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
                                       
10.830.822.621.32422.620.116.414.718.727.524.341.74832.7277082.7105.07
3.54.25.177.27.88.58.5910.610.81213.21515.716.619.619.62225.06
2000000000000000000000
3.35.16.19.676.58.4810.913.316.715.2172127.439.545.146.150.358.08
1.10.71.72.61.71.33.432.83.22.43.64.62.62.93.32.64.26.76.38
9.110.843.741.837.239.642.939.639.141.848.658.359.180.39492.194.3139.9161.7194.6
2.42.72.42.92.32.13.84.74.55.86.97812.414.130.131.132.133.539.78
00000000000000000000
00000000000000000000
1.62.41.93.92.93.33.735.26.17.26.39.98.213.724.958.952.746.541.71
6.78.98.910.9111111.911.913.71517.317.823.423.829.94065.965.965.965.95
0.60.30.21.41.10.910.40.41.81.61.41.61.61.41.32.62.12.74.74
11.314.313.419.117.317.320.42023.828.73332.542.94659.196.3158.5152.8148.6152.18
20.425.157.160.954.556.963.359.662.970.581.690.8102126.3153.1188.4252.8292.7310.3346.78
                                       
2.32.30.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.24
1419.260.561.262.363.564.664.664.765.475.482.185.493.198.4105.9114.9181.6189.3200.76
-2.1-2-9.9-12.9-16.2-14.6-8.6-6.4-3.9-0.73.28.215.328.345.85770.688.197.8115.43
800-200100300-300100-400-600-400-300-2,400-4,000-4,600-2,300-3,900-4,000-1,500-3,400-6,000-4,625
00000000000000000000
1519.350.948.84649.255.857.860.664.676.486.596.3119.3140.5159.1184.2266.5281.3311.8
0.50.30.82.30.61.11.311.11.21.11.41.21.51.72.62.42.32.93.73
2.63.33.76.75.55.47.855.87.178.48.59.112.414.817.117.721.425.73
0.30.30.90.90.801.20.51.51.91.90.60.82.65.73.53.21.810.41
070003000000000000000000
0.50.5000000000000002.5000
3.95.15.410.26.96.510.36.58.410.21010.410.513.219.820.925.221.825.329.88
1.10.7000.10.2000000000035.5000
0.40.60.811.31.50.411.73.52.91.71.92.20.51.20.10.10.10.11
0.30.20.11.20.40.40.10.10.10.20.30.821.22.618.219.416.816.918.89
1.81.50.92.21.82.10.51.11.83.73.22.53.93.43.119.45516.91719
5.76.66.312.48.78.610.87.610.213.913.212.914.416.622.940.380.238.742.348.88
20.725.957.261.254.757.866.665.470.878.589.699.4110.7135.9163.4199.4264.4305.2323.6360.68
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of LeMaitre Vascular provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand LeMaitre Vascular's financial health and stability.

Assets

LeMaitre Vascular's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that LeMaitre Vascular must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of LeMaitre Vascular after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into LeMaitre Vascular's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
000-1-2-316223371017221721262030
0011111122233344581199
0000000-2,0001,000000000-2,00000000
00-2-1-2000-4-2-2-300-1-1-130-9-13-11
000113233333235-167101312
000000000000000000000
0000000000124435441087
01-10-20573455111622191434352536
0-1-10-10-1-2-2-1-2-1-2-2-6-3-3-2-4-3-7
-1-2-1-13-992-5-1-5-6-7-3-17-28-7-24-52-61-10-24
-1-10-12-793-20-3-3-6-1-14-22-4-20-49-56-7-17
000000000000000000000
000-10000000-10000039-3900
12235000-2-2-10104142456225
11231000-2-3-3061-20-4-43213-9-7
----2.00------------1.00-2.00-4.00--1.00-
00000000-1-1-1-2-2-3-4-5-6-7-9-10-12
00016-11970-2-3-138-3-57-1414-1255
-0.210.12-2.21-1.52-3.51-0.163.814.491.083.392.494.329.1514.0616.4516.4610.4231.8230.2222.1529.49
000000000000000000000

LeMaitre Vascular stock margins

The LeMaitre Vascular margin analysis displays the gross margin, EBIT margin, as well as the profit margin of LeMaitre Vascular. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for LeMaitre Vascular.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the LeMaitre Vascular's sales revenue. A higher gross margin percentage indicates that the LeMaitre Vascular retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the LeMaitre Vascular's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the LeMaitre Vascular's total revenue generated. When comparing the revenue margin year over year, investors can gauge the LeMaitre Vascular's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the LeMaitre Vascular. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the LeMaitre Vascular's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

LeMaitre Vascular Margin History

LeMaitre Vascular Gross marginLeMaitre Vascular Profit marginLeMaitre Vascular EBIT marginLeMaitre Vascular Profit margin
2029e65.66 %24.67 %0 %
2028e65.66 %24.17 %0 %
2027e65.66 %26.45 %20.47 %
2026e65.66 %25.7 %20.56 %
2025e65.66 %24.84 %20.19 %
2024e65.66 %23.99 %19.85 %
202365.66 %19.22 %15.56 %
202264.87 %18.49 %12.74 %
202165.67 %23.58 %17.42 %
202065.38 %21.87 %16.38 %
201968.17 %18.09 %15.27 %
201869.98 %19.6 %21.69 %
201770.07 %20.91 %17.05 %
201670.52 %18.27 %11.88 %
201569.13 %14.16 %9.95 %
201468.07 %9.99 %5.49 %
201369.92 %6.98 %4.96 %
201272.13 %7.23 %4.59 %
201169.67 %9.01 %3.64 %
201074.33 %11.23 %10.7 %
200973.28 %7.47 %3.14 %
200869.61 %-2.46 %-6.78 %
200774.15 %-7 %-7 %
200673.12 %-0.87 %-3.47 %
200571.01 %4.56 %0.33 %
200470.23 %6.11 %3.44 %

LeMaitre Vascular Stock Sales Revenue, EBIT, Earnings per Share

The LeMaitre Vascular earnings per share therefore indicates how much revenue LeMaitre Vascular has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue LeMaitre Vascular earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates LeMaitre Vascular's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of LeMaitre Vascular’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating LeMaitre Vascular's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LeMaitre Vascular Revenue, EBIT and net profit per share

DateLeMaitre Vascular Sales per ShareLeMaitre Vascular EBIT per shareLeMaitre Vascular Earnings per Share
2029e14.88 undefined0 undefined0 undefined
2028e13.65 undefined0 undefined0 undefined
2027e12.93 undefined0 undefined2.65 undefined
2026e11.86 undefined0 undefined2.44 undefined
2025e10.95 undefined0 undefined2.21 undefined
2024e9.99 undefined0 undefined1.98 undefined
20238.63 undefined1.66 undefined1.34 undefined
20227.28 undefined1.35 undefined0.93 undefined
20217.18 undefined1.69 undefined1.25 undefined
20206.31 undefined1.38 undefined1.03 undefined
20195.77 undefined1.04 undefined0.88 undefined
20185.23 undefined1.02 undefined1.13 undefined
20175.05 undefined1.06 undefined0.86 undefined
20164.65 undefined0.85 undefined0.55 undefined
20154.28 undefined0.61 undefined0.43 undefined
20144.18 undefined0.42 undefined0.23 undefined
20134.08 undefined0.28 undefined0.2 undefined
20123.63 undefined0.26 undefined0.17 undefined
20113.61 undefined0.33 undefined0.13 undefined
20103.48 undefined0.39 undefined0.37 undefined
20093.2 undefined0.24 undefined0.1 undefined
20083.12 undefined-0.08 undefined-0.21 undefined
20072.69 undefined-0.19 undefined-0.19 undefined
20063.49 undefined-0.03 undefined-0.12 undefined
20053.53 undefined0.16 undefined0.01 undefined
20041.71 undefined0.1 undefined0.06 undefined

LeMaitre Vascular business model

LeMaitre Vascular Inc. is a global company that specializes in the development and marketing of medical devices and instruments for the diagnosis, treatment, and prevention of peripheral vascular diseases. The company was founded in 1983 by George D. LeMaitre, a former heart surgeon, with the goal of providing innovative and high-quality medical devices that meet the needs of patients and healthcare professionals. LeMaitre Vascular Inc. has become a leading provider of medical devices and instruments for the vascular surgical community and has offices worldwide. The company's business model focuses on the development and marketing of medical devices for peripheral vascular diseases, with an emphasis on quality, innovation, and effectiveness. LeMaitre Vascular Inc. collaborates with medical research institutions and clinicians to develop new products and improve existing ones. The company operates in three main areas: vascular access, endovascular, and surgery. LeMaitre Vascular Inc. offers a wide range of products for the diagnosis, treatment, and prevention of peripheral vascular diseases. Some of the main products include Avflo, Heparinase, XenoSure Aspirating Siphon, Dinamik, and Valvulotome. Overall, LeMaitre Vascular Inc. is committed to meeting the needs of healthcare professionals and patients and will continue to develop its products accordingly. LeMaitre Vascular is one of the most popular companies on Eulerpool.com.

LeMaitre Vascular SWOT Analysis

Strengths

LeMaitre Vascular Inc boasts a highly experienced and skilled management team capable of executing strategic decisions effectively. The company's established brand reputation and strong market presence provide a competitive advantage, allowing for easier market penetration and customer acquisition. LeMaitre Vascular also benefits from a diverse product portfolio, offering a wide range of innovative medical devices and solutions.

Weaknesses

One weakness of LeMaitre Vascular is its overdependence on specific product lines, potentially exposing the company to market fluctuations and unforeseen disruptions. Additionally, the company's limited distribution network in certain regions may hinder its expansion capabilities. Improved diversification and wider market coverage are areas that require attention.

Opportunities

The growing demand for minimally invasive medical procedures presents a significant opportunity for LeMaitre Vascular. By developing and promoting advanced technologies and solutions in this space, the company can tap into a burgeoning market segment. Furthermore, expanding its presence in untapped markets and forming strategic partnerships with healthcare centers and professionals can lead to increased revenue and market share.

Threats

LeMaitre Vascular operates in an industry characterized by intense competition and rapid technological advancements. This poses a threat to the company's market position, as competitors may introduce innovative products or engage in aggressive pricing strategies. Additionally, regulatory changes and uncertainties within the healthcare industry can disrupt business operations and impact revenue. Adopting proactive measures to stay ahead of market changes and conforming to evolving regulations is vital.

LeMaitre Vascular Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

LeMaitre Vascular Revenue by Segment

DateAmericasAsia PacificD EEMEAFrance and United KingdomGermanyGERMANYJ PJapanJAPANOther countriesUnited StatesUnited States-Federal
2023130.31 M USD12.08 M USD-51.1 M USD---------
2022109.44 M USD10.36 M USD-41.85 M USD---------
2021102.27 M USD10.03 M USD-42.13 M USD---------
202081.47 M USD8.7 M USD-39.19 M USD---------
201969.36 M USD8.39 M USD-39.48 M USD---------
201863.65 M USD6.6 M USD-35.32 M USD---------
2017------11.58 M USD---30.82 M USD58.47 M USD-
2016------10.35 M USD---28.36 M USD50.44 M USD-
2015------9.09 M USD---24.09 M USD45.18 M USD-
2014------7.64 M USD--2.21 M USD19.7 M USD41.55 M USD-
2013--6.94 M USD----2.41 M USD--15.96 M USD39.24 M USD-
2012----500,000 USD5.65 M USD--2.67 M USD-11.87 M USD-36.54 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

LeMaitre Vascular Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

LeMaitre Vascular historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

LeMaitre Vascular shares outstanding

The number of shares was LeMaitre Vascular in 2024 — This indicates how many shares 22.423 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue LeMaitre Vascular earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates LeMaitre Vascular's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of LeMaitre Vascular’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating LeMaitre Vascular's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LeMaitre Vascular dividend history and estimates

In 2024, LeMaitre Vascular paid a dividend amounting to 0.64 USD. Dividend means that LeMaitre Vascular distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for LeMaitre Vascular provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify LeMaitre Vascular’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating LeMaitre Vascular's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

LeMaitre Vascular Dividend History

DateLeMaitre Vascular Dividend
2029e0.58 undefined
2028e0.58 undefined
2027e0.58 undefined
2026e0.58 undefined
2025e0.58 undefined
2024e0.58 undefined
20230.56 undefined
20220.5 undefined
20210.44 undefined
20200.38 undefined
20190.34 undefined
20180.28 undefined
20170.22 undefined
20160.18 undefined
20150.16 undefined
20140.14 undefined
20130.12 undefined
20120.1 undefined
20110.08 undefined

LeMaitre Vascular dividend payout ratio

In 2024, LeMaitre Vascular had a payout ratio of 43.6%. The payout ratio indicates the percentage of the company's profits that LeMaitre Vascular distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for LeMaitre Vascular represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for LeMaitre Vascular could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate LeMaitre Vascular's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

LeMaitre Vascular Payout Ratio History

DateLeMaitre Vascular Payout ratio
2029e44.53 %
2028e45 %
2027e44.65 %
2026e43.94 %
2025e46.4 %
2024e43.6 %
202341.83 %
202253.76 %
202135.2 %
202036.54 %
201938.64 %
201824.78 %
201725.58 %
201632.73 %
201538.1 %
201460.87 %
201360 %
201262.5 %
201161.54 %
201041.83 %
200941.83 %
200841.83 %
200741.83 %
200641.83 %
200541.83 %
200441.83 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for LeMaitre Vascular.

LeMaitre Vascular latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.44 0.49  (10.44 %)2024 Q3
6/30/20240.48 0.52  (8.13 %)2024 Q2
3/31/20240.4 0.44  (11.39 %)2024 Q1
12/31/20230.36 0.38  (4.28 %)2023 Q4
9/30/20230.31 0.33  (6.93 %)2023 Q3
6/30/20230.32 0.36  (11.52 %)2023 Q2
3/31/20230.26 0.27  (5.26 %)2023 Q1
12/31/20220.26 0.25  (-5.2 %)2022 Q4
9/30/20220.28 0.25  (-11.69 %)2022 Q3
6/30/20220.27 0.16  (-40.81 %)2022 Q2
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the LeMaitre Vascular stock

Eulerpool World ESG Rating (EESG©)

44/ 100

🌱 Environment

48

👫 Social

44

🏛️ Governance

39

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

LeMaitre Vascular shareholders

%
Name
Stocks
Change
Date
13.67721 % BlackRock Institutional Trust Company, N.A.3,074,63643,0256/30/2024
8.80049 % Conestoga Capital Advisors, LLC1,978,35136,8509/30/2024
8.45621 % LeMaitre (George W)1,900,956-97,3787/16/2024
6.90370 % The Vanguard Group, Inc.1,551,9512,6326/30/2024
5.17523 % Copeland Capital Management, LLC1,163,39211,3189/30/2024
3.91249 % Geneva Capital Management LLC879,527-20,5116/30/2024
3.62061 % Ranger Investment Management, L.P.813,913-9,8006/30/2024
3.53007 % State Street Global Advisors (US)793,5604256/30/2024
3.15532 % Congress Asset Management Company, LLP709,31618,2959/30/2024
2.85237 % Dimensional Fund Advisors, L.P.641,213-21,0686/30/2024
1
2
3
4
5
...
10

LeMaitre Vascular Executives and Management Board

Mr. George LeMaitre

(58)
LeMaitre Vascular Chairman of the Board, Chief Executive Officer (since 1992)
Compensation 1.94 M

Mr. David Roberts

(58)
LeMaitre Vascular President, Director (since 1997)
Compensation 1.02 M

Mr. Joseph Pellegrino

(58)
LeMaitre Vascular Chief Financial Officer, Director (since 2005)
Compensation 963,578

Mr. Trent Kamke

(52)
LeMaitre Vascular Senior Vice President - Operations
Compensation 642,830

Mr. John O'Connor

(75)
LeMaitre Vascular Independent Director
Compensation 158,000
1
2
3
4
...
5

Most common questions regarding LeMaitre Vascular

What values and corporate philosophy does LeMaitre Vascular represent?

LeMaitre Vascular Inc represents a set of core values and a strong corporate philosophy. The company is committed to innovation, providing high-quality medical devices, and improving patient outcomes. LeMaitre Vascular focuses on delivering superior products in the field of vascular surgery and strives to address unmet clinical needs. Their emphasis on research and development reflects their dedication to advancing medical technology. With a customer-centric approach, LeMaitre Vascular aims to build lasting relationships with healthcare professionals and achieve sustainable growth. By prioritizing excellence, integrity, and teamwork, LeMaitre Vascular Inc demonstrates its commitment to improving vascular care worldwide.

In which countries and regions is LeMaitre Vascular primarily present?

LeMaitre Vascular Inc is primarily present in the United States, Canada, Europe, and Asia.

What significant milestones has the company LeMaitre Vascular achieved?

LeMaitre Vascular Inc has achieved several significant milestones. The company has successfully expanded its product portfolio, introducing innovative solutions in the field of vascular surgery. LeMaitre Vascular has also made notable strides in global market expansion, establishing a strong presence in over 85 countries. Furthermore, the company has demonstrated consistent revenue growth and a commitment to enhancing patient outcomes through continuous research and development efforts. With its dedication to improving vascular care and its consistent track record of success, LeMaitre Vascular Inc has solidified its position as a leading provider in the medical device industry.

What is the history and background of the company LeMaitre Vascular?

LeMaitre Vascular Inc, founded in 1983, is a leading provider of medical devices for the treatment of peripheral vascular disease. With its headquarters in Burlington, Massachusetts, the company specializes in the design, manufacturing, and distribution of innovative products used in vascular surgery. LeMaitre Vascular offers a comprehensive range of devices, including grafts, catheters, and implants, to address various vascular conditions. Over the years, the company has grown its presence globally, serving healthcare professionals and patients in more than 80 countries. LeMaitre Vascular Inc's commitment to excellence, continuous innovation, and focus on improving patient outcomes has solidified its position as a trusted leader in the vascular healthcare industry.

Who are the main competitors of LeMaitre Vascular in the market?

The main competitors of LeMaitre Vascular Inc in the market are Medtronic, Boston Scientific Corporation, and Edwards Lifesciences Corporation.

In which industries is LeMaitre Vascular primarily active?

LeMaitre Vascular Inc is primarily active in the medical equipment and supplies industry.

What is the business model of LeMaitre Vascular?

The business model of LeMaitre Vascular Inc is focused on designing, manufacturing, and marketing medical devices used in the treatment of peripheral vascular disease. The company primarily focuses on products related to the treatment of arteries and veins outside of the heart, including bypass graft surgery, carotid surgery, and dialysis access procedures. LeMaitre Vascular offers a wide range of products, including grafts, balloons, stents, and surgical laser consoles, among others. By providing innovative and high-quality medical devices, LeMaitre Vascular aims to improve patient outcomes and establish itself as a leader in the peripheral vascular market.

What is the P/E ratio of LeMaitre Vascular 2025?

The LeMaitre Vascular P/E ratio is 43.07.

What is the P/S ratio of LeMaitre Vascular 2025?

The LeMaitre Vascular P/S ratio is 8.69.

What is the Quality Investing of LeMaitre Vascular?

The Quality Investing for LeMaitre Vascular is 8/10.

What is the revenue of LeMaitre Vascular 2025?

The expected LeMaitre Vascular revenue is 246.1 M USD.

How high is the profit of LeMaitre Vascular 2025?

The expected LeMaitre Vascular profit is 49.68 M USD.

What is the business model of LeMaitre Vascular

LeMaitre Vascular Inc is a leading medical company specializing in the development and marketing of medical devices for the treatment of vascular diseases. The company is headquartered in the USA and has branches worldwide. LeMaitre Vascular's business model focuses on manufacturing specialized medical devices used in vascular surgery. The company offers a wide range of innovative products that contribute to improving the quality of life for patients with vascular diseases. One important sector of LeMaitre Vascular is the production of endoprostheses used to treat vessel occlusions or stenosis. The company also offers a wide range of balloon catheters that can be used to dilate narrowed or blocked vessels. Another key area of the company's business is the manufacturing of venous valves used in the treatment of venous diseases and chronic venous insufficiency. These products have proven to be highly effective and provide long-term relief for patients. In addition to manufacturing medical devices, LeMaitre Vascular also offers a wide range of services. The company is known for its high-quality customer service, working closely with doctors and medical professionals to ensure the effective use of their products. To further promote its growth, LeMaitre Vascular invests in research and development. The company has a team of talented researchers and developers focused on creating innovative devices and medical solutions that contribute to improving patient care. In recent years, LeMaitre Vascular has also established an increasing presence in the international market. The company has opened branches in Europe, Asia, and the Middle East to expand the reach of its products and grow its business in new markets. In summary, the business model of LeMaitre Vascular aims to manufacture innovative medical devices that contribute to improving the lives of patients with vascular diseases. The company offers a wide range of products and services, including endoprostheses, venous valves, and balloon catheters. LeMaitre Vascular is also a pioneer in research and development and strategically expanding its presence in the international market.

What is the LeMaitre Vascular dividend?

LeMaitre Vascular pays a dividend of 0.5 USD distributed over 4 payouts per year.

How often does LeMaitre Vascular pay dividends?

LeMaitre Vascular pays out a dividend 4 times a year.

What is the LeMaitre Vascular ISIN?

The ISIN of LeMaitre Vascular is US5255582018.

What is the LeMaitre Vascular WKN?

The WKN of LeMaitre Vascular is A0LB2B.

What is the LeMaitre Vascular ticker?

The ticker of LeMaitre Vascular is LMAT.

How much dividend does LeMaitre Vascular pay?

Over the past 12 months, LeMaitre Vascular paid a dividend of 0.56 USD . This corresponds to a dividend yield of about 0.59 %. For the coming 12 months, LeMaitre Vascular is expected to pay a dividend of 0.58 USD.

What is the dividend yield of LeMaitre Vascular?

The current dividend yield of LeMaitre Vascular is 0.59 %.

When does LeMaitre Vascular pay dividends?

LeMaitre Vascular pays a quarterly dividend. This is distributed in the months of April, June, September, December.

How secure is the dividend of LeMaitre Vascular?

LeMaitre Vascular paid dividends every year for the past 0 years.

What is the dividend of LeMaitre Vascular?

For the upcoming 12 months, dividends amounting to 0.58 USD are expected. This corresponds to a dividend yield of 0.64 %.

In which sector is LeMaitre Vascular located?

LeMaitre Vascular is assigned to the 'Health' sector.

Wann musste ich die Aktien von LeMaitre Vascular kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of LeMaitre Vascular from 12/5/2024 amounting to 0.16 USD, you needed to have the stock in your portfolio before the ex-date on 11/21/2024.

When did LeMaitre Vascular pay the last dividend?

The last dividend was paid out on 12/5/2024.

What was the dividend of LeMaitre Vascular in the year 2024?

In the year 2024, LeMaitre Vascular distributed 0.56 USD as dividends.

In which currency does LeMaitre Vascular pay out the dividend?

The dividends of LeMaitre Vascular are distributed in USD.

All fundamentals about LeMaitre Vascular

Our stock analysis for LeMaitre Vascular Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LeMaitre Vascular Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.